Tag: Peripheral nervous system

In January 2025, the U.S. Food and Drug Administration (FDA) approved Journavx, marking the first new oral painkiller class in over two decades. The answer to **what is the new opiate free drug?** is this innovative medication, offering a significant and safer alternative for managing moderate-to-severe acute pain.

In a major medical development, the FDA approved Journavx (suzetrigine) in January 2025, marking the first approval for a new class of pain medication in more than 20 years. This breakthrough offers a non-addictive option for treating moderate to severe acute pain, posing the question: What is the new acute pain pill?.